+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Fetal Bovine Serum Market 2024-2028

  • PDF Icon

    Report

  • 169 Pages
  • December 2023
  • Region: Global
  • TechNavio
  • ID: 5632876
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The fetal bovine serum market is forecasted to grow by USD 294.16 million during 2023-2028, accelerating at a CAGR of 5.25% during the forecast period. The report on the fetal bovine serum market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising adoption of stem cell applications, the increasing prevalence of chronic diseases, and livestock industry growth.

The fetal bovine serum market is segmented as below:

By Application

  • Biopharmaceuticals
  • Human and animal vaccine
  • Others

By End-user

  • Pharmaceutical and biopharmaceutical companies
  • Contract research organization
  • Academic and research organization

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing application in cell-based pharmaceutical research as one of the prime reasons driving the fetal bovine serum market growth during the next few years. Also, increased focus on disease management and the growing adoption of preventive care will lead to sizable demand in the market.

The report on the fetal bovine serum market covers the following areas:

  • Fetal bovine serum market sizing
  • Fetal bovine serum market forecast
  • Fetal bovine serum market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fetal bovine serum market vendors that include Animal Technologies Inc., Atlas Biologicals Inc., Bio Techne Corp., Corning Inc., Danaher Corp., GeminiBio, GeneTex Inc., Grifols SA, HiMedia Laboratories Pvt. Ltd., Itoham Yonekyu Holdings Inc., Merck KGaA, MP Biomedicals Inc., Nucleus Biologics, PAN Biotech, Rocky Mountain Biologicals, Sartorius AG, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., Tissue Culture Biologicals, and Celtic Molecular Diagnostics. Also, the fetal bovine serum market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global fetal bovine serum market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global fetal bovine serum market 2018 - 2022 ($ million)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Biopharmaceuticals - Market size and forecast 2023-2028
Exhibit 34: Chart on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
6.4 Human and animal vaccine - Market size and forecast 2023-2028
Exhibit 38: Chart on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Application
Exhibit 46: Market opportunity by Application ($ million)
Exhibit 47: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 50: Chart on Comparison by End-user
Exhibit 51: Data Table on Comparison by End-user
7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028
Exhibit 52: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
7.4 Contract research organization - Market size and forecast 2023-2028
Exhibit 56: Chart on Contract research organization - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Contract research organization - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Contract research organization - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Contract research organization - Year-over-year growth 2023-2028 (%)
7.5 Academic and research organization - Market size and forecast 2023-2028
Exhibit 60: Chart on Academic and research organization - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Academic and research organization - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Academic and research organization - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Academic and research organization - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 64: Market opportunity by End-user ($ million)
Exhibit 65: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Denmark - Market size and forecast 2023-2028
Exhibit 91: Chart on Denmark - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Denmark - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Denmark - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 India - Market size and forecast 2023-2028
Exhibit 103: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on India - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Animal Technologies Inc.
Exhibit 115: Animal Technologies Inc. - Overview
Exhibit 116: Animal Technologies Inc. - Product / Service
Exhibit 117: Animal Technologies Inc. - Key offerings
12.4 Atlas Biologicals Inc.
Exhibit 118: Atlas Biologicals Inc. - Overview
Exhibit 119: Atlas Biologicals Inc. - Product / Service
Exhibit 120: Atlas Biologicals Inc. - Key offerings
12.5 Bio Techne Corp.
Exhibit 121: Bio Techne Corp. - Overview
Exhibit 122: Bio Techne Corp. - Business segments
Exhibit 123: Bio Techne Corp. - Key offerings
Exhibit 124: Bio Techne Corp. - Segment focus
12.6 Corning Inc.
Exhibit 125: Corning Inc. - Overview
Exhibit 126: Corning Inc. - Business segments
Exhibit 127: Corning Inc. - Key news
Exhibit 128: Corning Inc. - Key offerings
Exhibit 129: Corning Inc. - Segment focus
12.7 Danaher Corp.
Exhibit 130: Danaher Corp. - Overview
Exhibit 131: Danaher Corp. - Business segments
Exhibit 132: Danaher Corp. - Key news
Exhibit 133: Danaher Corp. - Key offerings
Exhibit 134: Danaher Corp. - Segment focus
12.8 Grifols SA
Exhibit 135: Grifols SA - Overview
Exhibit 136: Grifols SA - Business segments
Exhibit 137: Grifols SA - Key offerings
Exhibit 138: Grifols SA - Segment focus
12.9 HiMedia Laboratories Pvt. Ltd.
Exhibit 139: HiMedia Laboratories Pvt. Ltd. - Overview
Exhibit 140: HiMedia Laboratories Pvt. Ltd. - Product / Service
Exhibit 141: HiMedia Laboratories Pvt. Ltd. - Key offerings
12.10 Itoham Yonekyu Holdings Inc.
Exhibit 142: Itoham Yonekyu Holdings Inc. - Overview
Exhibit 143: Itoham Yonekyu Holdings Inc. - Business segments
Exhibit 144: Itoham Yonekyu Holdings Inc. - Key offerings
Exhibit 145: Itoham Yonekyu Holdings Inc. - Segment focus
12.11 Merck KGaA
Exhibit 146: Merck KGaA - Overview
Exhibit 147: Merck KGaA - Business segments
Exhibit 148: Merck KGaA - Key news
Exhibit 149: Merck KGaA - Key offerings
Exhibit 150: Merck KGaA - Segment focus
12.12 PAN Biotech
Exhibit 151: PAN Biotech - Overview
Exhibit 152: PAN Biotech - Product / Service
Exhibit 153: PAN Biotech - Key offerings
12.13 Rocky Mountain Biologicals
Exhibit 154: Rocky Mountain Biologicals - Overview
Exhibit 155: Rocky Mountain Biologicals - Product / Service
Exhibit 156: Rocky Mountain Biologicals - Key offerings
12.14 Sartorius AG
Exhibit 157: Sartorius AG - Overview
Exhibit 158: Sartorius AG - Business segments
Exhibit 159: Sartorius AG - Key news
Exhibit 160: Sartorius AG - Key offerings
Exhibit 161: Sartorius AG - Segment focus
12.15 TCS Biosciences Ltd.
Exhibit 162: TCS Biosciences Ltd. - Overview
Exhibit 163: TCS Biosciences Ltd. - Product / Service
Exhibit 164: TCS Biosciences Ltd. - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 165: Thermo Fisher Scientific Inc. - Overview
Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
Exhibit 167: Thermo Fisher Scientific Inc. - Key news
Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus
12.17 Tissue Culture Biologicals
Exhibit 170: Tissue Culture Biologicals - Overview
Exhibit 171: Tissue Culture Biologicals - Product / Service
Exhibit 172: Tissue Culture Biologicals - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Application
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 18: Historic Market Size - Data Table on global fetal bovine serum market 2018 - 2022 ($ million)
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
Exhibit 34: Chart on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
Exhibit 38: Chart on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibit 46: Market opportunity by Application ($ million)
Exhibit 47: Data Table on Market opportunity by Application ($ million)
Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
Exhibit 50: Chart on Comparison by End-user
Exhibit 51: Data Table on Comparison by End-user
Exhibit 52: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibit 56: Chart on Contract research organization - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Contract research organization - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Contract research organization - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Contract research organization - Year-over-year growth 2023-2028 (%)
Exhibit 60: Chart on Academic and research organization - Market size and forecast 2023-2028 ($ million)
Exhibit 61: Data Table on Academic and research organization - Market size and forecast 2023-2028 ($ million)
Exhibit 62: Chart on Academic and research organization - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Academic and research organization - Year-over-year growth 2023-2028 (%)
Exhibit 64: Market opportunity by End-user ($ million)
Exhibit 65: Data Table on Market opportunity by End-user ($ million)
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibit 91: Chart on Denmark - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Denmark - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Denmark - Year-over-year growth 2023-2028 (%)
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 103: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibit 104: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibit 105: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
Exhibit 111: Overview on factors of disruption
Exhibit 112: Impact of key risks on business
Exhibit 113: Vendors covered
Exhibit 114: Matrix on vendor position and classification
Exhibit 115: Animal Technologies Inc. - Overview
Exhibit 116: Animal Technologies Inc. - Product / Service
Exhibit 117: Animal Technologies Inc. - Key offerings
Exhibit 118: Atlas Biologicals Inc. - Overview
Exhibit 119: Atlas Biologicals Inc. - Product / Service
Exhibit 120: Atlas Biologicals Inc. - Key offerings
Exhibit 121: Bio Techne Corp. - Overview
Exhibit 122: Bio Techne Corp. - Business segments
Exhibit 123: Bio Techne Corp. - Key offerings
Exhibit 124: Bio Techne Corp. - Segment focus
Exhibit 125: Corning Inc. - Overview
Exhibit 126: Corning Inc. - Business segments
Exhibit 127: Corning Inc. - Key news
Exhibit 128: Corning Inc. - Key offerings
Exhibit 129: Corning Inc. - Segment focus
Exhibit 130: Danaher Corp. - Overview
Exhibit 131: Danaher Corp. - Business segments
Exhibit 132: Danaher Corp. - Key news
Exhibit 133: Danaher Corp. - Key offerings
Exhibit 134: Danaher Corp. - Segment focus
Exhibit 135: Grifols SA - Overview
Exhibit 136: Grifols SA - Business segments
Exhibit 137: Grifols SA - Key offerings
Exhibit 138: Grifols SA - Segment focus
Exhibit 139: HiMedia Laboratories Pvt. Ltd. - Overview
Exhibit 140: HiMedia Laboratories Pvt. Ltd. - Product / Service
Exhibit 141: HiMedia Laboratories Pvt. Ltd. - Key offerings
Exhibit 142: Itoham Yonekyu Holdings Inc. - Overview
Exhibit 143: Itoham Yonekyu Holdings Inc. - Business segments
Exhibit 144: Itoham Yonekyu Holdings Inc. - Key offerings
Exhibit 145: Itoham Yonekyu Holdings Inc. - Segment focus
Exhibit 146: Merck KGaA - Overview
Exhibit 147: Merck KGaA - Business segments
Exhibit 148: Merck KGaA - Key news
Exhibit 149: Merck KGaA - Key offerings
Exhibit 150: Merck KGaA - Segment focus
Exhibit 151: PAN Biotech - Overview
Exhibit 152: PAN Biotech - Product / Service
Exhibit 153: PAN Biotech - Key offerings
Exhibit 154: Rocky Mountain Biologicals - Overview
Exhibit 155: Rocky Mountain Biologicals - Product / Service
Exhibit 156: Rocky Mountain Biologicals - Key offerings
Exhibit 157: Sartorius AG - Overview
Exhibit 158: Sartorius AG - Business segments
Exhibit 159: Sartorius AG - Key news
Exhibit 160: Sartorius AG - Key offerings
Exhibit 161: Sartorius AG - Segment focus
Exhibit 162: TCS Biosciences Ltd. - Overview
Exhibit 163: TCS Biosciences Ltd. - Product / Service
Exhibit 164: TCS Biosciences Ltd. - Key offerings
Exhibit 165: Thermo Fisher Scientific Inc. - Overview
Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
Exhibit 167: Thermo Fisher Scientific Inc. - Key news
Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 170: Tissue Culture Biologicals - Overview
Exhibit 171: Tissue Culture Biologicals - Product / Service
Exhibit 172: Tissue Culture Biologicals - Key offerings
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
Exhibit 175: Currency conversion rates for US$
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
Exhibit 179: List of abbreviations

Executive Summary

The analyst recognizes the following companies as the key players in the global fetal bovine serum market: Animal Technologies Inc., Atlas Biologicals Inc., Bio Techne Corp., Corning Inc., Danaher Corp., GeminiBio, GeneTex Inc., Grifols SA, HiMedia Laboratories Pvt. Ltd., Itoham Yonekyu Holdings Inc., Merck KGaA, MP Biomedicals Inc., Nucleus Biologics, PAN Biotech, Rocky Mountain Biologicals, Sartorius AG, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., Tissue Culture Biologicals, and Celtic Molecular Diagnostics.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing application in cell-based pharmaceutical research.'

According to the report, one of the major drivers for this market is the rising adoption of stem cell applications.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Animal Technologies Inc.
  • Atlas Biologicals Inc.
  • Bio Techne Corp.
  • Corning Inc.
  • Danaher Corp.
  • GeminiBio
  • GeneTex Inc.
  • Grifols SA
  • HiMedia Laboratories Pvt. Ltd.
  • Itoham Yonekyu Holdings Inc.
  • Merck KGaA
  • MP Biomedicals Inc.
  • Nucleus Biologics
  • PAN Biotech
  • Rocky Mountain Biologicals
  • Sartorius AG
  • TCS Biosciences Ltd.
  • Thermo Fisher Scientific Inc.
  • Tissue Culture Biologicals
  • Celtic Molecular Diagnostics